|Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium …|
SJ Kim, K Kim, BS Kim, CY Kim, C Suh, J Huh, SW Lee, JS Kim, J Cho, ...
|SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group|
YL Kwong, WS Kim, ST Lim, SJ Kim, T Tang, E Tse, AYH Leung, CS Chim
Blood 120 (15), 2973-2980, 2012
|A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma|
HY Yoo, MK Sung, SH Lee, S Kim, H Lee, S Park, SC Kim, B Lee, K Rho, ...
Nature genetics 46 (4), 371-375, 2014
|PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase|
YL Kwong, TSY Chan, D Tan, SJ Kim, LM Poon, B Mow, PL Khong, ...
Blood 129 (17), 2437-2442, 2017
|Expression of HIF-1á, CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer|
SJ Kim, ZN Rabbani, MW Dewhirst, Z Vujaskovic, RT Vollmer, ...
Lung cancer 49 (3), 325-335, 2005
|A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis|
SJ Kim, DH Yoon, A Jaccard, WJ Chng, ST Lim, H Hong, Y Park, ...
The lancet oncology 17 (3), 389-400, 2016
|Multicenter phase II study of bendamustine plus rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma|
K Ohmachi, N Niitsu, T Uchida, SJ Kim, K Ando, N Takahashi, ...
Journal of clinical oncology 31 (17), 2103-2109, 2013
|Ki-67 expression is predictive of prognosis in patients with stage I/II extranodal NK/T-cell lymphoma, nasal type|
SJ Kim, BS Kim, CW Choi, J Choi, I Kim, YH Lee, JS Kim
Annals of oncology 18 (8), 1382-1387, 2007
|Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: analysis from the Asia Lymphoma Study Group|
SJ Kim, C Hsu, YQ Song, K Tay, XN Hong, J Cao, JS Kim, HS Eom, ...
European journal of cancer 49 (16), 3486-3496, 2013
|Type II enteropathy‐associated T‐cell lymphoma: A multicenter analysis from the Asia Lymphoma Study Group|
E Tse, H Gill, F Loong, SJ Kim, SB Ng, T Tang, YH Ko, WJ Chng, ST Lim, ...
American journal of hematology 87 (7), 663-668, 2012
|Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: surgical resection followed by chemotherapy versus chemotherapy alone|
SJ Kim, HJ Kang, JS Kim, SY Oh, CW Choi, SI Lee, JH Won, MK Kim, ...
Blood, The Journal of the American Society of Hematology 117 (6), 1958-1965, 2011
|Carbonic Anhydrase IX in Early-Stage Non–Small Cell Lung Cancer|
SJ Kim, ZN Rabbani, RT Vollmer, EG Schreiber, E Oosterwijk, ...
Clinical cancer research 10 (23), 7925-7933, 2004
|Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL)|
SJ Kim, CW Choi, YC Mun, SY Oh, HJ Kang, SI Lee, JH Won, MK Kim, ...
BMC cancer 11 (1), 321, 2011
|Bortezomib in combination with CHOP as first-line treatment for patients with stage III/IV peripheral T-cell lymphomas: a multicentre, single-arm, phase 2 trial|
SJ Kim, DH Yoon, HJ Kang, JS Kim, SK Park, HJ Kim, J Lee, BY Ryoo, ...
European Journal of Cancer 48 (17), 3223-3231, 2012
|Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II study|
SJ Kim, JW Lee, CW Jung, CK Min, B Cho, HJ Shin, JS Chung, H Kim, ...
haematologica 95 (11), 1935-1942, 2010
|Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type|
S Lee, HY Park, SY Kang, SJ Kim, J Hwang, S Lee, SH Kwak, KS Park, ...
Oncotarget 6 (19), 17764, 2015
|Clinical outcomes and prognostic factors in patients with breast diffuse large B cell lymphoma; Consortium for Improving Survival of Lymphoma (CISL) study|
HY Yhim, HJ Kang, YH Choi, SJ Kim, WS Kim, YS Chae, JS Kim, CW Choi, ...
BMC cancer 10 (1), 321, 2010
|Genomic profiling combined with gene expression profiling in primary central nervous system lymphoma|
CO Sung, SC Kim, S Karnan, K Karube, HJ Shin, DH Nam, YL Suh, ...
Blood, The Journal of the American Society of Hematology 117 (4), 1291-1300, 2011
|Concurrent chemoradiotherapy followed by L-asparaginase-containing chemotherapy, VIDL, for localized nasal extranodal NK/T cell lymphoma: CISL08-01 phase II study|
SJ Kim, DH Yang, JS Kim, JY Kwak, HS Eom, DS Hong, JH Won, JH Lee, ...
Annals of hematology 93 (11), 1895-1901, 2014
|Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL)|
YR Kim, JS Kim, YH Min, DH Yoon, HJ Shin, YC Mun, Y Park, YR Do, ...
Journal of Hematology & Oncology 5 (1), 49, 2012